Participants sought to test long-term effects of popular type 2 diabetes drugs
Researchers at Washington University School of Medicine in St. Louis are seeking volunteers to participate in a study comparing the long-term risks and benefits of four widely prescribed diabetes...
View ArticleType 2 diabetes drug adds new warning for serious injection site reactions
New information has been added to the safety label of the injectable type 2 diabetes drug Bydureon to include a new warning that some people using the medication have experienced serious injection-site...
View ArticleLong-term pancreatic cancer risks with class of type 2 diabetes drugs still...
Drugs in a class of Type 2 diabetes medications known as DPP-4 inhibitors may not increase the short-term risk of pancreatic cancer, but the long-term risks are still unknown, according to a new study...
View ArticleTop best-selling Type 2 diabetes drugs linked to cancer
Nearly half of the top-selling Type 2 diabetes drugs come from a class of drugs known as incretin mimetics. They have been linked to a painful inflammation of the pancreas called acute pancreatitis,...
View ArticleLawsuits claim type 2 diabetes drugs caused pancreatic cancer
Ann Falcone of Staten Island, NY is suing two different drug companies alleging their type 2 diabetes treatments caused her to develop pancreatic cancer. Falcone claims she began taking Januvia...
View ArticleTrials underway on experimental diabetes drug
Novo Nordisk’s new oral diabetes drug is proving to be just as effective as its injectable counterpart in clinical studies. The drug, known as OG217SC, is an oral version of the company’s experimental...
View ArticleNew black box warnings added to type 2 diabetes drugs
The safety labels of four type 2 diabetes drugs have been updated to include new black box warnings for thyroid cancer, according to the Food and Drug Administration (FDA). The new warnings were added...
View ArticleNovo Nordisk becomes top diabetes drug seller with Victoza
Danish drug company Novo Nordisk has become the top seller of diabetes medications thanks to its blockbuster type 2 diabetes treatment Victoza (liraglutide), which brought in a whopping $2 billion in...
View ArticleNewer diabetes drugs linked to acute pancreatitis
Diabetics treated with a newer classes of diabetes drugs have double the risk of being hospitalized with acute pancreatitis, according to a study published in JAMA Internal Medicine. The drug class,...
View ArticleStudy raises concerns about class of type 2 diabetes drugs
A class of type 2 diabetes drugs used to reduce blood sugar levels may actually promote the release of sugars into the blood, according to a paper published in the Journal of Biological Chemistry. The...
View Article
